Latest news
TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance - The Manila TimesThe Manila Times · Mon, 03 Aug 2026 11:19:39 GMTDid Briumvi’s Strong Trial Data and New Schizophrenia Study Just Shift TG Therapeutics’ (TGTX) Investment Narrative? - simplywall.stsimplywall.st · Wed, 29 Jul 2026 07:00:00 GMT